Management Team

Michael Martin joined Neomatrix as Chairman of the Board in September, 2009. Mike currently serves as the President of Waveland Capital Group LLC, in Irvine, California. As a key member of Waveland's Executive Management Committee, Mike also provides operational oversight to Waveland's private equity portfolio companies in support of the corporate finance team. Prior to joining Waveland, Mike was President of the $8 billion oncology division of AmerisourceBergen Corporation (NYSE:ABC), a $70 billion "Fortune 27" company. Mike was instrumental in strengthening that division's core competency as the premier group purchasing organization in the nation, while simultaneously expanding its reach in the oncology marketplace as a complete physician services organization. Additionally, under Mike's leadership and guidance, the division dedicated significant resources to the development and implementation of a network-wide data aggregation initiative, which will ultimately lead to the improvement of patient care through improved therapy compliance and increased practice efficiency. Mike's sterling leadership and organization background encompasses many aspects of healthcare and life sciences, including executive management roles at Tensys Medical, Medibuy, Premier Inc. and GE Medical Systems. As Waveland continues to grow as a dynamic and robust alternative investment platform focused on healthcare, information technology and energy, Mike is a key element in contributing to and managing that growth. Mike received his BA from West Liberty State College in West Virginia. He also serves or has served on the Board of Directors for La Jolla Institute for Allergy and Immunology, Tensys Medical, Crossflo Systems and Waveland portfolio companies (Vesta Medical, LLC, NeoMatrix, LLC, and Fertile Earth Corporation).